Suchergebnisse - "Xia, Zhongjun"

PubPharm (76)

21

Preparation method of nitrogen and bromine co-doped graphene quantum dot material

enthalten in: Europäisches Patentamt | 2022

von XIA ZHONGJUN | LIU XUEYONG | ZHENG DAIFANG | +2

22

Development of a Risk Assessment Model for Early Grade ≥ 3 Infection During the First 3 Months in Patients Newly Diagnosed With Multiple Myeloma Based on a Multicenter, Real-World Analysis in China

enthalten in: Frontiers in oncology | 2022

von Shang, Y. | Wang, W. | Liang, Y. | +6

23

Carfilzomib modulates tumor microenvironment to potentiate immune checkpoint therapy for cancer

enthalten in: EMBO molecular medicine | 2022

von Zhou, Q. | Liang, J. | Yang, T. | +14

24

Efficacy and safety comparison between R-CHOP and modified NHL-BFM-90 regimens in children and adolescents with diffuse large B-cell lymphoma

enthalten in: Annals of hematology | 2022

von Guan, J. | Sun, F. | Wang, J. | +11

25

Efficacy and safety comparison between R-CHOP and modified NHL-BFM-90 regimens in children and adolescents with diffuse large B-cell lymphoma

enthalten in: Annals of hematology | 2022

von Guan, J. | Sun, F. | Wang, J. | +11

26

Efficacy and safety comparison between R-CHOP and modified NHL-BFM-90 regimens in children and adolescents with diffuse large B-cell lymphoma

enthalten in: Annals of hematology | 2022

von Guan, J. | Sun, F. | Wang, J. | +11

27

Ibrutinib as monotherapy versus combination therapy in Chinese patients with relapsed/refractory mantle cell lymphoma : A multicenter study

enthalten in: Cancer Medicine | 2022

von Zhang, Y. | Liu, P. | Cai, J. | +19

28

Carfilzomib modulates tumor microenvironment to potentiate immune checkpoint therapy for cancer

enthalten in: EMBO Molecular Medicine | 2022

von Zhou, Q. | Liang, J. | Yang, T. | +14

29

Sequential P-GEMOX and radiotherapy for early-stage extranodal natural killer/T-cell lymphoma : A multicenter study

enthalten in: American journal of hematology | 2021

von Zhang, Y. | Ma, S. | Cai, J. | +17

30

A nomogram prognostic index for risk-stratification in diffuse large B-cell lymphoma in the rituximab era : a multi-institutional cohort study

enthalten in: British journal of cancer | 2021

von Cai, J. | Tian, X. | Ma, S. | +15